Back to All Events

Advancing the Development of Pediatric Therapeutics (ADEPT) 10: Addressing Challenges in Neonatal Product Development – Leveraging Rare Disease Frameworks


Join the FDA and Critical Path Institute for the Advancing the Development of Pediatric Therapeutics (ADEPT) Workshop, focused on addressing challenges in neonatal product development.

This two-day event will spotlight:

  • Ethical and regulatory considerations in neonatal trials

  • Innovative approaches to data collection and study design

  • Strategies to advance safe and effective neonatal therapies

Audience: Researchers, clinicians, regulatory scientists, and industry professionals dedicated to pediatric and neonatal drug development.

Source: www.fda.gov/news-events/fda-meetings-conferences-and-workshops/advancing-development-pediatric-therapeutics-adept-10-addressing-challenges-neonatal-product?utm_medium=email&utm_source=govdelivery
Previous
December 2

2nd Annual Clinical Outsourcing Group CRO Summit